Diabetes status of subjects in the Hawaii component of the MEC study at different follow-up times
| . | N . | Diabetes cases . | Prevalence (%) . |
|---|---|---|---|
| Baseline questionnaire (1993–1996) | 103,898 | 10,028 | 9.7 |
| Follow-up questionnaire (1999–2003) | 86,732 | 9,964 | 11.5 |
| Medication use questionnaire (2003–2006) | 39,787 | 4,425 | 11.1 |
| Linkage with BCBS (2007)* | 67,465 | 11,375 | 16.9 |
| Linkage with KP (2007) | 20,539 | 4,003 | 19.5 |
| . | N . | Diabetes cases . | Prevalence (%) . |
|---|---|---|---|
| Baseline questionnaire (1993–1996) | 103,898 | 10,028 | 9.7 |
| Follow-up questionnaire (1999–2003) | 86,732 | 9,964 | 11.5 |
| Medication use questionnaire (2003–2006) | 39,787 | 4,425 | 11.1 |
| Linkage with BCBS (2007)* | 67,465 | 11,375 | 16.9 |
| Linkage with KP (2007) | 20,539 | 4,003 | 19.5 |
*Number of MEC subjects provided to BCBS minus KP members; health plan membership is not established for noncase subjects.